This application requests funds to continue the highly successful Cancer Biology training program at the Stanford University School of Medicine entitled """"""""Cancer Etiology, Prevention, Detection and Diagnosis"""""""". This Interdisciplinary Program provides our faculty, especially those in non-degree granting departments (e.g., Radiation Oncology and Pathology), the opportunity to recruit and mentor top-notch graduate students and postdoctoral fellows. The goal of this program is to provide the very best training for its predoctoral and postdoctoral trainees so that they become successful and independent leaders in the field of cancer research. The program accomplishes this goal by providing each graduate and postdoctoral trainee with a broad and comprehensive curriculum, a vast array of educational resources, such as seminars, lectures, conferences and workshops specifically geared towards the biology of cancer, a faculty comprised of 82 exceptional preceptors spanning 23 departments with extensive experience in cancer research mentoring, and an unparalleled research environment. In addition, postdoctoral trainees are expected to participate in the same seminar series, conferences and presentations as graduate students, but will only audit courses that will aid them in their research and achieving their career goals. As a prelude to our postdoctoral trainees becoming independent scientists, they are expected to learn to effectively write grants, and obtain their own individual funding. They will also learn more extensive professional skills such as lab management and mentoring to more successfully compete in today's job market. A key strength of the program is its true multidisciplinary approach to cancer research incorporating such fields as molecular biology, genetics, cell biology, computational biology and bioinformatics, comparative oncology, developmental biology, tumor biology, as well as biotechnology development for use in cancer diagnosis and therapeutics. The success of the Cancer Biology training program is demonstrated by its track record of attracting outstanding and talented predoctoral and postdoctoral candidates to Stanford University and placing graduates of the program in high profile competitive cancer research positions. To aid in the further development of the training program we have recently created a four-member Advisory Board consisting of highly accomplished members of the Stanford research community and one external advisor. Finally, during the next five year period we will develop a Cancer Systems Biology research focus to train the researchers in cancer biology who are adept at the computational analysis of highly complex related data sets.

Public Health Relevance

This is the renewal application for the T32 predoctoral and postdoctoral training grant in Cancer Etiology, Prevention, Detection and Diagnosis that is in its 36th year. The program has developed a thriving and innovative training environment as well as an effective administrative infrastructure that has been very successful in attracting highly qualified predoctoral and postdoctoral fellows to Stanford University. This next funding period, we intend to build on this success and to refine further the program to prepare our predoctoral and postdoctoral trainees to become independent and self-reliant scientists, who take positions as junior faculty in academic or research institutions, biotechnology industries or government laboratories

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009302-37
Application #
8658374
Study Section
Subcommittee B - Comprehensiveness (NCI)
Program Officer
Lim, Susan E
Project Start
1977-09-15
Project End
2018-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
37
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
City
Stanford
State
CA
Country
United States
Zip Code
94304
Kariolis, Mihalis S; Miao, Yu Rebecca; Diep, Anh et al. (2017) Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest 127:183-198
Chuang, Chen-Hua; Greenside, Peyton G; Rogers, Zoë N et al. (2017) Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis. Nat Med 23:291-300
García-Nieto, Pablo E; Schwartz, Erin K; King, Devin A et al. (2017) Carcinogen susceptibility is regulated by genome architecture and predicts cancer mutagenesis. EMBO J 36:2829-2843
Jeong, Youngtae; Hoang, Ngoc T; Lovejoy, Alexander et al. (2017) Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discov 7:86-101
Spitzer, Matthew H; Carmi, Yaron; Reticker-Flynn, Nathan E et al. (2017) Systemic Immunity Is Required for Effective Cancer Immunotherapy. Cell 168:487-502.e15
Kunimoto, Koshi; Bayly, Roy D; Vladar, Eszter K et al. (2017) Disruption of Core Planar Cell Polarity Signaling Regulates Renal Tubule Morphogenesis but Is Not Cystogenic. Curr Biol 27:3120-3131.e4
Dulken, Ben W; Leeman, Dena S; Boutet, Stéphane C et al. (2017) Single-Cell Transcriptomic Analysis Defines Heterogeneity and Transcriptional Dynamics in the Adult Neural Stem Cell Lineage. Cell Rep 18:777-790
Han, Kyuho; Jeng, Edwin E; Hess, Gaelen T et al. (2017) Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol 35:463-474
Chang, Junlei; Mancuso, Michael R; Maier, Carolina et al. (2017) Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nat Med 23:450-460
Benham-Pyle, Blair W; Sim, Joo Yong; Hart, Kevin C et al. (2016) Increasing ?-catenin/Wnt3A activity levels drive mechanical strain-induced cell cycle progression through mitosis. Elife 5:

Showing the most recent 10 out of 323 publications